Case Study: CSL Behring GmbH – Strengthening Global Access to Fibrinogen Replacement Therapies
Case StudiesHeadquarters: Marburg, GermanyOffering: RiaSTAP® (Human Fibrinogen Concentrate, lyophilized powder for injection) Detailed Case Study In 2025, CSL Behring GmbH — one of the world’s leading biopharmaceutical companies specializing in plasma-derived and recombinant therapeutic products — took a decisive step to meet the escalating global demand for human fibrinogen concentrates. With congenital and acquired fibrinogen deficiencies […]